News
Needham Reiterates Buy on Clearside Biomedical, Maintains $4 Price Target
11 Apr 24
News, Price Target, Reiteration, Analyst Ratings
12 Health Care Stocks Moving In Wednesday's After-Market Session
27 Mar 24
Movers
12 Health Care Stocks Moving In Thursday's Intraday Session
14 Mar 24
Movers
HC Wainwright & Co. Reiterates Buy on Clearside Biomedical, Maintains $6 Price Target
14 Mar 24
News, Price Target, Reiteration, Analyst Ratings
JMP Securities Reiterates Market Outperform on Clearside Biomedical, Maintains $5 Price Target
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Wedbush Maintains Outperform on Clearside Biomedical, Lowers Price Target to $4
13 Mar 24
News, Price Target, Analyst Ratings
Needham Reiterates Buy on Clearside Biomedical, Maintains $4 Price Target
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Clearside Biomedical: Q4 Earnings Insights
12 Mar 24
Earnings
Clearside Biomedical Q4 2023 Adj EPS $(0.08) Beats $(0.09) Estimate, Sales $6.30M Beat $4.43M Estimate
12 Mar 24
Earnings, Earnings Beats, News
Earnings Scheduled For March 12, 2024
12 Mar 24
Earnings
12 Health Care Stocks Moving In Monday's After-Market Session
11 Mar 24
Movers
Preview: Clearside Biomedical's Earnings
11 Mar 24
Earnings
12 Health Care Stocks Moving In Tuesday's After-Market Session
20 Feb 24
Movers
Clearside Biomedical Announces Pricing Of $15M Registered Direct Offering With Institutional Investors And An Existing Stockholder, Providing For The Purchase And Sale Of 11,111,111 Shares Of Common Stock And Accompanying Warrant
7 Feb 24
News, Offerings
Press releases
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
16 Apr 24
Biotech, News, Management, Press Releases, General
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
2 Apr 24
News, Press Releases
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
18 Mar 24
News, Management, Press Releases
Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences?
13 Mar 24
Opinion, Press Releases
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024
29 Feb 24
News, Press Releases